Susquehanna International Group, LLP Citius Pharmaceuticals, Inc. Call Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 11, 2023	SELL	$1.08 - $1.65 $115,344 - $176,220	-106,800 Reduced 72.11%	41,300 $49,000
Q1 2023 May 16, 2023	SELL	$0.78 - $1.42 $19,734 - $35,926	-25,300 Reduced 14.59%	148,100 $173,000
Q4 2022 Feb 14, 2023	BUY	$0.79 - $1.28 $17,380 - $28,160	22,000 Added 14.53%	173,400 $136,000
Q3 2022 Nov 14, 2022	BUY	$0.14 - $1.33 $1,652 - $15,694	11,800 Added 8.45%	151,400 $183,000
Q2 2022 Aug 15, 2022	SELL	$0.88 - $1.87 $45,584 - $96,866	-51,800 Reduced 27.06%	139,600 $128,000
Q1 2022 May 16, 2022	SELL	$1.38 - $1.89 $265,926 - $364,203	-192,700 Reduced 50.17%	191,400 $343,000
Q4 2021 Feb 14, 2022	SELL	$1.51 - $2.2 $257,455 - $375,100	-170,500 Reduced 30.74%	384,100 $592,000
Q3 2021 Nov 15, 2021	BUY	$1.74 - $2.6 $826,326 - $1.23 Million	474,900 Added 595.86%	554,600 $1.13 Million
Q2 2021 Aug 11, 2021	BUY	$1.51 - $4.23 $120,347 - $337,131	79,700 New	79,700 $277,000

23.4M

83.1K

32.1K

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $29.2M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.